Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging

被引：58
|
作者：
Le, DA
Lipton, SA [1 ]
机构：
[1] Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA
[2] Massachusetts Gen Hosp, Stroke & Neurovasc Regulat Lab, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Stroke & Neurovasc Regulat Lab, Boston, MA USA
来源：
DRUGS & AGING | 2001年 / 18卷 / 10期
关键词：
D O I：
10.2165/00002512-200118100-00001
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
The N-methyl-D-aspartate (NMDA) receptor complex is a subtype of glutamate receptor and its dysfunction is involved in many neurological disorders associated with aging, including chronic pain, depression, stroke and Parkinson's disease. Multiple clinical trials using NMDA receptor antagonists have been aborted mainly due to the severe psychomimetic adverse effects of these drugs that occur before concentrations can reach an adequate level in the brain. In this review, we present the evidence that clinically safer NMDA antagonists such as memantine and nitroglycerin., and the combination drug nitro-memantine, are promising as drugs in treating neurodegenerative diseases.
引用
收藏
页码：717 / 724
页数：8
相关论文
共 50 条
  • [31] GLYCINE ANTAGONISTS ATTENUATE N-METHYL-D-ASPARTATE (NMDA) MEDIATED BRAIN INJURY
    UCKELE, J
    MCDONALD, JW
    JOHNSTON, M
    SILVERSTEIN, F
    PEDIATRIC RESEARCH, 1989, 25 (04) : A362 - A362
  • [32] Activation of the N-methyl-D-aspartate (NMDA) receptor by adenosine antagonists in brain cell membranes of newborn piglets
    Marro, PJ
    Ballesteros, JR
    Zhu, A
    Mishra, OP
    Delivoria-Papadopoulos, M
    PEDIATRIC RESEARCH, 1999, 45 (04) : 68A - 68A
  • [33] Activation of the N-Methyl-D-Aspartate (NMDA) Receptor by Adenosine Antagonists in Brain Cell Membranes of Newborn Piglets
    Peter J Marro
    Juan R Ballesteros
    Anli Zhu
    Om P Mishra
    Maria Delivoria-Papadopoulos
    Pediatric Research, 1999, 45 : 68 - 68
  • [34] Effect of N-methyl-D-aspartate Receptor (NMDA-R) antagonists in a rat model of neuropathic pain
    Swartjes, M.
    Aarts, L.
    Dahan, A.
    Morariu, A.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2010, 27 (01) : 219 - 219
  • [35] A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists
    Liu, Wenwu
    Jiang, Xiaowen
    Zu, Yuxin
    Yang, Yue
    Liu, Yaqian
    Sun, Xue
    Xu, Zihua
    Ding, Huaiwei
    Zhao, Qingchun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
  • [36] Assembly of N-methyl-D-aspartate (NMDA) receptors
    McIlhinney, RAJ
    Philipps, E
    Le Bourdelles, B
    Grimwood, S
    Wafford, K
    Sandhu, S
    Whiting, P
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 865 - 868
  • [37] Characterization of the N-methyl-d-aspartate (NMDA) receptor in the embryonic chick brain
    S. O. P. Jacobsson
    Henrietta Hedin
    Åke Sellström
    Christopher J. Fowler
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 357 : 625 - 633
  • [38] Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites
    Morris, Patrick J.
    Moaddel, Ruin
    Zanos, Panos
    Moore, Curtis E.
    Gould, Todd
    Zarate, Carlos A., Jr.
    Thomas, Craig J.
    ORGANIC LETTERS, 2017, 19 (17) : 4572 - 4575
  • [39] ATTENUATION OF HIPPOCAMPAL INHIBITION BY A NMDA (N-METHYL-D-ASPARTATE) RECEPTOR ANTAGONIST
    CAPEK, R
    ESPLIN, B
    NEUROSCIENCE LETTERS, 1991, 129 (01) : 145 - 148
  • [40] Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity
    Haberny, KA
    Paule, MG
    Scallet, AC
    Sistare, FD
    Lester, DS
    Hanig, JP
    Slikker, W
    TOXICOLOGICAL SCIENCES, 2002, 68 (01) : 9 - 17
12345